
Start intervention early to curb SVA, say experts
Consultant paediatrician and child disability activist Datuk Dr Amar Singh HSS said short video addiction (SVA) is now a global issue, and Malaysia is no exception.
ALSO READ: When habit takes a toll on real life
'Social media platforms like TikTok are attracting many young adults in Malaysia. Local studies have shown signs of TikTok addiction among youth,' he said when contacted.
One reason, he explained, lies in how these platforms are designed.
'They use algorithms that prioritise engagement, which often amplifies negative or sensational content. This kind of content is more attention-grabbing, which helps generate views and platform monetisation,' he said.
Supporting this, a study by Hong Kong-based Digital Business Lab showed TikTok's explosive growth in Malaysia.
ALSO READ: Hooked on autoplay, infinite scrolling and dopamine hits
In the first half of 2024 alone, the platform recorded 81.7 million downloads, a 6.6% increase from the previous year.
ByteDance's advertising data also reported 28.68 million TikTok users aged 18 and above in Malaysia, equivalent to 84.4% of total internet users.
'As of January 2024, TikTok is the most popular social media platform, with 21.9% of users saying they love its engaging short-form videos,' the report stated.
Child expert Syaza Soraya Sauli of Universiti Teknologi Malaysia stressed the importance of early intervention, beginning at home and in pre-schools.
'More parents are giving gadgets to their children, especially phones. This leads to what's now being called 'virtual autism',' she said, referring to children who exhibit autism-like behaviours due to prolonged screen exposure and limited social interaction.
'Many children aged below seven are already showing signs such as short attention spans, avoidance of physical activities and limited soft skills.
'They complain about hand pain when writing, give up on colouring quickly, yet can sit through hours of short videos.'
These children often lack gross motor skills such as coordination and strength, she added.
When assessed, Syaza said they appear 'autistic', but the root issue is screen overexposure, not neurodevelopmental disorders.
'Our current education system doesn't help. There's only one teacher per 25 students and national policy only mandates 20 minutes of structured free-play in pre-schools daily – far too little to build physical skills.'
Syaza said addressing SVA requires cooperation between parents and schools.
'Parents must reduce their own screen time alongside their children's, gradually. It's not easy because children may become emotionally distressed when gadgets are taken away,' she said, recommending alternative outlets like outdoor play to release energy and emotions.
'While parents do their part at home, education policymakers must also ensure balance in the school curriculum by combining digital literacy with physical, hands-on learning. There should be more experiential learning,' she added.
'Balance is key to preventing SVA from becoming a major problem, as seen in Singapore and China,' said Syaza, who is currently pursuing her PhD in educational psychology.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


New Straits Times
5 hours ago
- New Straits Times
WHO: Malnutrition reaching 'alarming levels' in Gaza
GENEVA: Malnutrition rates are reaching "alarming levels" in the Gaza Strip, the World Health Organisation warned Sunday, saying the "deliberate blocking" of aid was entirely preventable and had cost many lives. "Malnutrition is on a dangerous trajectory in the Gaza Strip, marked by a spike in deaths in July," the WHO said in a statement. Of the 74 recorded malnutrition-related deaths in 2025, 63 had occurred in July -- including 24 children under five, one child aged over five, and 38 adults, it added. "Most of these people were declared dead on arrival at health facilities or died shortly after, their bodies showing clear signs of severe wasting," the UN health agency said. "The crisis remains entirely preventable. Deliberate blocking and delay of large-scale food, health, and humanitarian aid has cost many lives." Nearly one in five children under five in Gaza City is now acutely malnourished, the WHO said, citing its Nutrition Cluster partners. It said the percentage of children aged six to 59 months suffering from acute malnutrition had tripled in the city since June, making it the worst-hit area in the Palestinian territory. In Khan Yunis and middle Gaza, those rates have doubled in less than a month, it added. "These figures are likely an underestimation due to the severe access and security constraints preventing many families from reaching health facilities," the WHO said. Israel on Sunday began a limited "tactical pause" in military operations to allow the UN and aid agencies to tackle a deepening hunger crisis. But the WHO called for sustained efforts to "flood" the Gaza Strip with diverse, nutritious food, and for the expedited delivery of therapeutic supplies for children and vulnerable groups, plus essential medicines and supplies. "This flow must remain consistent and unhindered to support recovery and prevent further deterioration", the Geneva-based agency said. - AFP


New Straits Times
2 days ago
- New Straits Times
UN agency: Almost a third of Gazans 'not eating for days'
ROME: Almost a third of people in Gaza are "not eating for days", the United Nations food aid agency told AFP on Friday, saying the crisis has reached "new and astonishing levels of desperation." The Rome-based World Food Programme had previously warned of a "critical risk of famine" in war-ravaged Gaza, over which international condemnation of Israel's actions has been growing. "Nearly one person in three is not eating for days. Malnutrition is surging with 90,000 women and children in urgent need of treatment," a WFP statement said. It said that 470,000 people are expected to face "catastrophic hunger" – the most critical category under the UN's Integrated Food Security Phase classification – between May and September this year. "Food aid is the only way for people to access any food as food prices are through the roof," the WFP said. "People are dying from lack of humanitarian assistance." Aid groups have warned of surging numbers of malnourished children in Gaza, which Israel placed under an aid blockade in March amid its war with Hamas.


Malaysian Reserve
3 days ago
- Malaysian Reserve
Lilly completes acquisition of Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk
INDIANAPOLIS, July 25, 2025 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Verve Therapeutics, Inc. (Nasdaq: VERV). Verve is a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease. 'This acquisition unlocks the opportunity to potentially transform the treatment paradigm for millions of patients worldwide by delivering lifelong cardiovascular risk reduction with a one-and-done treatment,' said Ruth Gimeno, Lilly group vice president, Diabetes and Metabolic Research and Development. 'We are excited to welcome Verve colleagues to Lilly and work together to develop innovative genetic medicines for cardiometabolic disease.' About LillyLilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure our medicines are accessible and affordable. To learn more, visit and or follow us on Facebook, Instagram, and LinkedIn. F-LLY Cautionary Statement Regarding Forward-Looking StatementsThis press release contains forward-looking statements regarding Lilly's acquisition of Verve, regarding prospective benefits of the acquisition and Verve's gene editing programs for cardiovascular disease, regarding Verve's product candidates and ongoing clinical and preclinical development, and regarding Lilly's development of programs for cardiovascular disease and advancement of cardiometabolic health medicines. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. Forward-looking statements reflect current beliefs and expectations; however, these statements involve inherent risks and uncertainties, including with respect to drug research, development and commercialization, Lilly's evaluation of the accounting treatment of the acquisition and its potential impact on its financial results and financial guidance, regulatory changes and developments, the impact of global macroeconomic conditions, including trade and other global disputes and interruptions, including related to tariffs, trade protection measures, and similar restrictions, risks that the acquisition disrupts current plans and operations or adversely affect employee retention, and any legal proceedings that have been or may be instituted related to the acquisition. Actual results could differ materially due to various factors, risks and uncertainties. Among other things, there can be no guarantee that Lilly will realize the expected benefits of the acquisition, that product candidates will be approved on anticipated timelines or at all, that any products, if approved, will be commercially successful, that all or any of the contingent consideration will become payable on the terms described herein or at all, that Lilly's financial results will be consistent with its expected 2025 guidance or that Lilly can reliably predict the impact of the acquisition on its financial results or financial guidance. For further discussion of these and other risks and uncertainties, see Lilly's most recent Form 10-K and Form 10-Q filings with the U.S. Securities and Exchange Commission. Except as required by law, Lilly undertakes no duty to update forward-looking statements to reflect events after the date of this press release. Refer to: Ashley Hennessey; gentry_ashley_jo@ 317-416-4363 (Media) Michael Czapar; czapar_michael_c@ 317-617-0983 (Investors)